Health Press Release – Weekly Newsletter for July 5-12, 2010

Health Press Release – Weekly Newsletter for July 5-12, 2010

Monday, July 12, 2010

Circadin is Approved in the EU for Treatment of Primary Insomnia in Patients Aged 55 or Over for up to 3 Months

TEL AVIV, Israel, July 5, 2010 – Neurim Pharmaceuticals (www.Neurim.com) confirmed today
that the European Commission (EC) has approved a change in treatment duration
with Circadin from 3 to 13 weeks (3 months). Circadin is indicated for the
treatment of primary insomnia in patients who are aged 55 or over.

The approval was based [...]

Finnish Pharmaceutical Innovation: Free Flowing Granulate

PDG Dry Granulation as Valid Alternative to Wet Granulation
HELSINKI, Finland, July 5, 2010 – Standard methods in pharmaceutical production often reach their
technological limits – be it wet granulation, roller compaction or direct
compression. The Finnish company Atacama Labs – www.atacamalabs.com -
with its proprietary pneumatic dry granulation technology extends this limit
successfully and provides free flowing granules [...]

Elsevier and International Society of Geriatric Oncology Launch Journal of Geriatric Oncology

New Journal Will Publish Research in the Developing Area of Geriatric Oncology

OXFORD, England, July 6, 2010 – Elsevier, the world-leading publisher of scientific, technical and
medical information products and services, and the International Society of
Geriatric Oncology (SIOG) announced today the launch of the Journal of
Geriatric Oncology (www.geriatriconcology.net). The journal is focused
on advancing research in the [...]

Helsinn and Mundipharma Sign New Contract for Palonosetron in Asian Countries

Helsinn's Second-Generation 5-HT3 RA Aloxi Expands its Presence in Asia Through the Agreement Signed With Mundipharma

LUGANO, Switzerland, July 6, 2010 – Helsinn Healthcare SA and Mundipharma International
Corporation Ltd. announce the signature of a Distribution and Licensing
Agreement for Helsinn's product palonosetron in Malesia, Philippines and
Singapore.
Aloxi(R) is a second generation 5-HT3 receptor [...]

EXCLAIM Study Publication in Annals of Internal Medicine Shows that Extended Anticoagulant Prophylaxis with Enoxaparin is Beneficial in Acutely Ill Medical Patients

Patients With Restricted Mobility, Elderly and Women Subgroups Drive the Patients' Benefit

NEW YORK, July 6, 2010 – The Steering Committee of the EXCLAIM study that explored the
benefit of extended prophylaxis of venous thrombo embolism (VTE) with
enoxaparin in acutely ill medical patients, announced today the publication
of the comprehensive study results in the peer-reviewed journal Annals [...]

NeuroFocus Reveals Groundbreaking Role That ‘Little Moments of Luxury’ Play in Economically Distressed Times, Introduces Luxury Perceptual Framework

New Methodology For Marketers Seeking Recessionary Solutions Measures Consumers' Subconscious Responses Across Eight Dimensions to Brands, Products, Packaging, In-Store Displays, Advertising, and Customer Service

BERKELEY, California, July 6, 2010 – As the economy sputters, the brain seeks relief in what the world's
leading neuromarketing company has identified as "little moments of luxury."
This finding lies at the [...]

Presentations at the Third European Stereotactic Radiation Therapy and Whole Body Radiotherapy Workshop Highlight Clinical Outcomes and Emerging Trends

Results Presented in Spine, Lung, Liver and Prostate Treatment Emphasized the Benefits of Whole Body Radiosurgery

SUNNYVALE, California, July 6, 2010 – Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of
radiosurgery, today announced highlights from the Third European Stereotactic
Radiation Therapy and Whole Body Radiotherapy Workshop, held in Brussels,
Belgium on May 28 and May [...]

Design Award for Hitachi Medical Corporation Japan

ESSEN, Germany, July 6, 2010 – With its outstanding and innovative design, the HI VISION
Preirus, an ultrasound-based diagnostic imaging platform used to scan
internal body organs including the unborn baby, impressed the jury of one of
the most prestigious international design competitions. In the "red dot
award: product design 2010" the HI VISION Preirus ultrasound platform was
awarded [...]

Ground-Breaking Web Platform Revolutionizes Biomedical Research

BioHub-Online.org to Slash $1 Billion in Wasted Research Funds Through Community Networking

TORONTO, July 6, 2010 – BioHub Inc., announced today the launch of BioHub-Online.org, a first-of-
its-kind online platform to facilitate global networking and collaboration
among research scientists.
Antibodies are biomedical research reagents used for hundreds of
thousands of experiments globally. The global [...]

Knowledge Workers Divulge ‘Trade Secrets’ at Global Intelligence Forum

DUNGARVAN, Ireland, July 6, 2010 – What can the CIA learn from GE? What can a pediatric urologist
researching intersexuality learn from a forensic anthropologist working mass
disasters? All use "intelligence" in their own ways to make more informed
decisions, but rarely do they share with each other what works and what
doesn't.

Now, for [...]

New President and CEO Appointed at Ocean Nutrition Canada Limited

DARTMOUTH, Canada, July 6, 2010 – Ocean Nutrition Canada Limited – Long time Ocean Nutrition Canada Ltd.
(ONC) President and CEO, Robert Orr, will make way for a new CEO to lead the
company's next growth phase, with particular focus on international
expansion efforts and the food sector.

Martin Jamieson, a 30 year international [...]

Telemedicine Technology Market in Brazil, Russia, India, China (BRIC) Worth US $418.4 Million by the Year 2014

DALLAS, Texas, July 7, 2010 – According to the new market research report, "Telemedicine Market in
Brazil, Russia, India, China (BRIC) – Advanced technologies, Global Forecast"
published by MarketsandMarkets (www.marketsandmarkets.com), the BRIC
telemedicine is expected to reach a market size of $418.4 million by the year
2014, at a CAGR of 15.8% from 2009-2014. The BRIC telemedicine technology
market [...]

Elsevier Appoints Top Diabetes and Endocrinology Researchers as Editors

OXFORD, England, July 7, 2010 – Elsevier is pleased to announce the appointment of prominent new
Editors-in-Chief to three key endocrinology titles, effective immediately.

Editor-in-Chief, Metabolism: Christos S. Mantzoros, MD DSc FACP FACE
Christos Mantzoros is clinical research lead at the Department of
Endocrinology, Diabetes and Metabolism at Beth Israel [...]

Pioneering Use of Mobile Technology to Conduct Clinical Trials in Emerging Economies

BRUSSELS, July 7, 2010 – Last week, at the fourth annual Clinical Trials in Emerging Economies
conference, Margaret Ann Snowden, Director of Biostatistics and Data
Management at Aeras Global TB Vaccine Foundation, and Daragh Ryan of Cmed
Technology, presented a case study of the application of the latest in
clinical data technology to a large Phase II clinical [...]

2010 International Health Promotion Awards Symposium, Recognizing Innovative Health Programs Around the World, Scheduled for Rome, Italy, December 6-7, 2010

URAC and GKEN Seek Nominations at https://www.aihpa.org
WASHINGTON, July 7, 2010 – The inaugural International Health Promotion Awards Symposium
(www.aihpa.org), which recognizes and promotes innovative programs
that can significantly improve health around the world, will be held in Rome,
Italy on December 6-7, 2010.

(Logo: photos.prnewswire.com/prnh/20100422/URACLOGO)
Established by two leaders in health [...]

Cardiac Concepts Enrolls First Patients in Pilot Trial in Europe for the RespiCardia(TM) System

Trial Underway for the First Implantable System to Treat Heart Failure Patients with Central Sleep Apnea

MINNEAPOLIS, July 7, 2010 – Cardiac Concepts, Inc., a developer of medical devices to treat Heart
Failure patients who experience breathing disturbances during sleep,
announced today enrollment of the first European patients in a Pilot Clinical
Trial. The purpose of the Pilot [...]

REYATAZ(R) (atazanavir) Capsules Approved for Paediatric Use by The European Commission

PARIS, June 7, 2010 – Bristol-Myers Squibb announced that on 5th of July, the European
Commission has approved boosted REYATAZ(R) (atazanavir sulfate) capsules to
treat HIV-1 infection in paediatric patients aged six to eighteen years and
greater than 15 kg, as part of combination HIV therapy.(1) This decision
grants marketing authorisation in the 27 countries of the European [...]

InteRNA Technologies Announces Establishment of Scientific Advisory Board

UTRECHT, the Netherlands, July 8, 2010 – InteRNA Technologies B.V., a biopharmaceutical company focusing on the
development of intelligent microRNA (miRNA)-based therapeutics for cancer,
announces the establishment of its Scientific Advisory Board (SAB). The SAB
will further guide the Company in the development of cancer therapies based
on the unique functions of its proprietary miRNAs.

[...]

First English Vineyard to go Supercharged

Sometimes Known as Supercharged or Premium Organic, an East Sussex Vineyard is to be the First in England to Produce Wine Using Biodynamic Principles

SEDLESCOMBE, England, July 8, 2010 – Established 30 years ago as England's first organic wine producer Roy
Cook, owner and wine maker at Sedlescombe Vineyard, has taken the next step
in sustainability by [...]

Kiadis Pharma Receives IND Approval From FDA to Start Pivotal Clinical Trial With ATIR(TM) in the United States

AMSTERDAM, July 8, 2010 – Biopharmaceutical Company Kiadis Pharma announced today that it has
received approval for its Investigational New Drug (IND) application with the
US Food and Drug Administration (FDA) to start the pivotal clinical study for
its product ATIR(TM) in the United States. Kiadis Pharma is currently
enrolling patients in a multinational pivotal clinical study at [...]

Enrollment Underway in CLARITY-AF Study to Compare Efficacy, Safety and Efficiency of Two Catheter Ablation Technologies

WATERLOO, Belgium, July 8, 2010 – Biosense Webster, Inc., a worldwide leader in the diagnosis and
treatment of cardiac arrhythmias, announces that more than 10 patients have
now been enrolled in the CLARITY-study ("CLARITY-AF"), comparing the
efficacy, safety and efficiency of CARTO(R) 3 System guided radiofrequency
ablation using the NAVISTAR(R) THERMOCOOL(R) catheter versus fluoroscopy
guided radiofrequency ablation using the [...]

Unprecedented Donation Made by Mrs. Lily Safra to the Institute for Brain and Spinal Cord Disorders in Paris

PARIS, July 8, 2010 – Professor Gerard Saillant, President of the Institute for
Brain and Spinal Cord Disorders (ICM), announced today an unprecedented
donation of EUR8,000,000 from Mrs. Lily Safra. It is the largest single
donation made by a private individual to the ICM.

Professor Saillant will officially thank Mrs. Safra for this
generous donation [...]

arGEN-X Granted Broad Patent Covering its Unique SIMPLE Antibody(TM) Platform

Novel Platform Set to Transform Human Therapeutic Antibody Discovery & Development

ROTTERDAM, The Netherlands, July 8, 2010 – arGEN-X, a biopharmaceutical company focused on the discovery
and development of human monoclonal antibodies using its proprietary SIMPLE
Antibody(TM) platform, announces that it has been granted the first patent
covering the platform. The patent GB2461546B, has been granted by the [...]

New Report Patient Monitoring Emerging Markets (BRIC – Brazil, Russia, India and China) 2010 – 2014 Published by MarketsandMarkets

DALLAS, July 8, 2010 – According to a new market research report, 'Emerging Markets
BRIC (Brazil, Russia, India and China) Patient Monitoring Market (2010 -
2015), published by MarketsandMarkets (www.marketsandmarkets.com), the
total BRIC patient monitoring devices market is expected to be worth US$3,075
million by 2015, and the China market is expected to account for nearly 62.9%
of the [...]

Lialda(R) – Shire Files Suit Against Cadila Healthcare Limited, Doing Business as Zydus Cadila and Zydus Pharmaceuticals (USA), Inc.

DUBLIN and PHILADELPHIA, July 8, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces that its subsidiaries Shire Development
Inc. and Shire Pharmaceutical Development Inc. have filed a lawsuit in the
U.S. District Court for the District of Delaware against Cadila Healthcare
Limited, doing business as Zydus Cadila and Zydus Pharmaceuticals (USA), Inc.
(collectively [...]

New Reports on Cancer/Oncology Market July Update by MarketsandMarkets

DALLAS, July 8, 2010 – MarketsandMarkets published new market research reports in
Cancer/Oncology industry reports

Global Oncology Pharmaceuticals & Therapeutics Market (
www.marketsandmarkets.com/Market-Reports/oncology-pharmaceuticals-ther
apeutics-arket-152.html)

(Due to the length of these URLs, it may be necessary to copy and paste
this hyperlink into your Internet browser's URL address field. Remove the
space if one [...]

Elsevier and Legacy Interactive(R) Partner to Launch iPhone App for Medical Students, Residents and Faculty

Top Doc App Offers Interactive Medical Quizzes, Real World Applications
PHILADELPHIA, July 8, 2010 – Elsevier, a world leader in health care, medical publishing and online
solutions, and video game developer and publisher Legacy Interactive(R),
announced today the release of Top Doc, an iPhone app that features medical
content and quizzes designed to let medical students, residents and [...]

Boston Scientific Announces First Patient Enrollment in MultiSENSE Clinical Trial

NATICK, Massachusetts, July 8, 2010 – Boston Scientific Corporation (NYSE: BSX) today announced
enrollment of the first patient in its MultiSENSE clinical trial. The trial
is designed to evaluate multiple physiologic sensors in the Company's
COGNIS(TM) cardiac resynchronization therapy defibrillators (CRT-Ds). Boston
Scientific plans to use the trial data to help develop a clinical alert that
identifies the early [...]

‘Include Veterinary Care in Holiday Plans,’ Advises the Royal College of Veterinary Surgeons

LONDON, July 8, 2010 – If you are holidaying with your pet this summer, remember to find out
about the arrangements for out-of-hours emergencies at a local veterinary
practice before you go, advises the Royal College of Veterinary Surgeons
(RCVS).

Veterinary surgeons across the UK are required under RCVS guidelines to
make provision for out-of-hours [...]

Silence Therapeutics Expands RNAi Structural Modification IP Portfolio With Issuance of New U.S. Patent

Second Recent Patent Issuance Related to Innovative Zamore 'Design Rules'

LONDON, July 7, 2010 – Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company")
announces the issuance of United States patent 7,750,144, titled Methods and
Compositions for Enhancing Efficacy and Specificity of RNA Silencing, by the
United States Patent and Trademark Office (USPTO). The issued patent
generally claims methods [...]

An Event in the Veterinary Community: REQUEST First Guidelines are now Available

PARIS, July 7, 2010 – REQUEST – a group of European veterinary experts in anti-infective
diseases – organised a specific session during the last WSAVA Congress in
Geneva, the 4th of June 2010.

To view the Multimedia News Release, please click:
multivu.prnewswire.com/mnr/prne/vetoquinol/42450/
The objective was to deliver [...]

Dementia Awareness Week

LONDON, July 7, 2010 – For this year's Dementia Awareness Week (4-10 July), journalist, author
and problem page editor, Virginia Ironside, is joining up with national care
provider, Barchester Healthcare, and Alzheimer's Society to launch some new
children's books!

'Visiting Grandad's new home' and 'Visiting Gran's new home' are
original, brand-new and beautifully illustrated books, [...]